Long-Acting HIV Shot Shows Durable Results in Real World

1 source1 article First seen 1 day ago Updated 1 day ago Spain Truth score 38

Save Like Comments Compare coverage

Summary

Long-acting cabotegravir plus rilpivirine maintains viral suppression for nearly 2 years in most people living with HIV receiving routine care in Spain. Medscape Medical News

Description from Medscape.

Who is covering this

Medscape Center Factuality: Mostly factual US 1 day ago
Long-Acting HIV Shot Shows Durable Results in Real World
Long-acting cabotegravir plus rilpivirine maintains viral suppression for nearly 2 years in most people living with HIV receiving routine care in Spain. Medscape Medical News

Comments

Comments need JavaScript.

Truth score

38/100Weakly supported

Independent outlets: 1
Source reliability: 65/100
Sides of the spectrum covering it: 1/3
Propaganda risk: 0/100

How well the story is corroborated by independent, reliable outlets across the spectrum. Not a fact-check of each claim. How the truth score works

Coverage by lean

Centre 100%100%

Left: 0
Centre: 1
Right: 0
Not rated: 0

How lean is counted

Source quality

Average reliability: 65/100 (Mostly factual)
Low-credibility outlets: 0%
State media: 0%
Opinion pieces: 0%

Where ratings come from

Where the coverage comes from

United States1

In this story

Medscape Medical News

Filter the stories

Sources Ratings and details

Long-Acting HIV Shot Shows Durable Results in Real World

Summary

Who is covering this

Comments

Summary

Who is covering this

Comments

Related stories

FDA Psychiatry Digest: October 2026

The ‘Emotional Whiplash’ of Modern Primary Care

Atopic Symptoms Reported by Hormone Therapy Users

Medicare Finalizes 2027 Physician Fee Schedule With Pay Cuts

Is Your Patient’s Depression Really a Body-Clock Problem?

The ‘First True Neural Implant’ Is Taking a Big Step Forward